L. Perlaky et al., NUCLEOLAR AND NUCLEAR ABERRATIONS IN HUMAN LOX TUMOR-CELLS FOLLOWING TREATMENT WITH P120 ANTISENSE OLIGONUCLEOTIDE ISIS-3466, Cancer letters, 74(1-2), 1993, pp. 125-135
Previous reports from this laboratory have shown marked cytocidal effe
cts of the ISIS-3466 antisense phosphorothioate oligodeoxynucleotide t
o the human nucleolar protein p120 on human cancer cell lines in vitro
and inhibition of tumor growth in vivo in an i.p./i.p. LOX cell model
(L. Perlaky et al. Anti-Cancer Drug Design 8:3-14, 1993). In this stu
dy, light and fluorescence microscopy showed that the number of LOX ce
lls in mitosis decreased by 50% after incubation for 4 h in 0.2-0.4 mu
M antisense oligonucleotide; a 70% reduction in cell number was found
from 8-72 h post-treatment. In addition, marked unravelling of nucleo
lar structures and chromatin fragmentation was found after a 4-h incub
ation. The nucleolar unravelling occurred in varying degrees ranging f
rom partial unfolding to almost complete separation of the strands of
nucleolar residues. Twenty four hours post-treatment, immunofluorescen
ce staining with the anti-p120 monoclonal antibody showed reduced nucl
eolar protein p120 and translocation of the p120 protein from the nucl
eoli to the nucleoplasm. Analysis of the mechanisms of the nucleolar u
nravelling and inhibition of mitosis will provide further understandin
g of the cytocidal effects of the ISIS-3466 antisense oligonucleotide.